# A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

> **NCT01556776** · PHASE3 · COMPLETED · sponsor: **German CLL Study Group** · enrollment: 89 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** lenalidomide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01556776
- **Lead sponsor:** German CLL Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-20
- **Primary completion:** 2016-03
- **Final completion:** 2021-01-14
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2022-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01556776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01556776, "A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01556776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*